Microvesicle release drives cycles of mitophagy flux disruption and inflammatory amplification in sepsis-induced

Rui Song1, Yinrui Ma1, Junfang Wan1

  • 1Department of Critical Care Medicine and Anesthesiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, People's Republic of China.

Insights

Sepsis causes heart dysfunction via mitochondrial damage and inflammation. This study reveals disrupted mitophagy and amplified inflammatory signals as key drivers, offering new therapeutic targets for sepsis patients.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Immunology

Background:

  • Sepsis-induced myocardial dysfunction is a major cause of mortality.
  • The molecular mechanisms underlying sepsis-related heart dysfunction are not fully understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms of sepsis-induced myocardial dysfunction.
  • To identify therapeutic targets for mitigating sepsis-related cardiac injury.

Main Methods:

  • Utilized cecal ligation and puncture (CLP) mouse models and lipopolysaccharide (LPS)-treated HL-1 cell models.
  • Employed advanced imaging and molecular analyses to investigate mitochondrial dynamics and inflammatory pathways.
  • Assessed mitophagy flux, reactive oxygen species (ROS) production, and microvesicle release.

Main Results:

  • DRP1-mediated mitochondrial fission and excessive ROS accumulation disrupt mitophagy flux.
  • Elevated ROS activates the RIP1/RIP3 pathway, impairing mitophagy and releasing mitochondrial components.
  • Released microvesicles amplify inflammation via cGAS-STING and RIP1/RIP3 pathways, increasing DAMPs and PAMPs.

Conclusions:

  • Two critical vicious cycles—mitophagy disruption and DAMP/PAMP amplification—drive sepsis-induced myocardial injury.
  • Targeting these pathways offers potential therapeutic strategies for sepsis patients.